Oramed Pharmaceuticals annual shares outstanding
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Oramed Pharmaceuticals Shares Outstanding History (ORMP)
Oramed Pharmaceuticals reported 39.3M shares outstanding at the end of fiscal 2025.
View full Oramed Pharmaceuticals company overviewOramed Pharmaceuticals annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 39.3M | −644,539 | −1.61% |
| 2024 | 2024-12-31 | 39.9M | −419,434 | −1.04% |
| 2023 | 2023-12-31 | 40.3M | 775,091 | +1.96% |
| 2022 | 2022-12-31 | 39.6M | 4.3M | +12.10% |
| 2021 | 2021-08-31 | 35.3M | 11.6M | +49.07% |
| 2020 | 2020-08-31 | 23.7M | 6.3M | +36.20% |
| 2019 | 2019-08-31 | 17.4M | 13,484 | +0.08% |
| 2018 | 2018-08-31 | 17.4M | 3.7M | +27.08% |
| 2017 | 2017-08-31 | 13.7M | 485,105 | +3.68% |
| 2016 | 2016-08-31 | 13.2M | 1.6M | +14.01% |
| 2015 | 2015-08-31 | 11.6M | 1.5M | +14.46% |
| 2014 | 2014-08-31 | 10.1M | 2.2M | +27.27% |
| 2013 | 2013-08-31 | 7.9M | 1.3M | +18.94% |
| 2012 | 2012-08-31 | 6.7M | −10.09B | −99.93% |
| 2011 | 2011-08-31 | 10.10B | — | — |
Oramed Pharmaceuticals quarterly shares outstanding
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
As of Jan 22, 2013
As of Jan 23, 2013
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q1.22
Q2.22
Q3.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 41.3M | 469,124 | +1.15% |
| Q1 2026 | 2026-03-31 | 40.9M | 75,626 | +0.19% |
| Q4 2025 | 2025-12-31 | 39.3M | −644,539 | −1.61% |
| Q3 2025 | 2025-09-30 | 40.8M | 628,651 | +1.56% |
| Q2 2025 | 2025-06-30 | 40.8M | 216,163 | +0.53% |
| Q1 2025 | 2025-03-31 | 40.9M | 331,295 | +0.82% |
| Q4 2024 | 2024-12-31 | 39.9M | −419,434 | −1.04% |
| Q3 2024 | 2024-09-30 | 40.2M | −73,113 | −0.18% |
| Q2 2024 | 2024-06-30 | 40.6M | 409,528 | +1.02% |
| Q1 2024 | 2024-03-31 | 40.5M | 549,181 | +1.37% |
| Q4 2023 | 2023-12-31 | 40.3M | 775,091 | +1.96% |
| Q3 2023 | 2023-09-30 | 40.3M | 1.2M | +2.99% |
| Q2 2023 | 2023-06-30 | 40.2M | 1.7M | +4.29% |
| Q1 2023 | 2023-03-31 | 40.0M | 1.4M | +3.65% |
| Q4 2022 | 2022-12-31 | 39.6M | 1.4M | +3.68% |
| Q3 2022 · Sep 30 | 2022-09-30 | 39.1M | 1.0M | +2.70% |
| Q3 2022 · Jun 30 | 2022-06-30 | 38.6M | 3.3M | +9.27% |
| Q2 2022 | 2022-03-31 | 38.6M | 8.0M | +26.34% |
| Q1 2022 · Dec 31 | 2021-12-31 | 38.2M | 9.9M | +34.89% |
| Q1 2022 · Nov 30 | 2021-11-30 | 38.1M | 14.3M | +59.95% |
| Q4 2021 | 2021-08-31 | 35.3M | 11.6M | +49.07% |
| Q3 2021 | 2021-05-31 | 30.5M | 7.2M | +31.13% |
| Q2 2021 | 2021-02-28 | 28.3M | 5.2M | +22.50% |
| Q1 2021 | 2020-11-30 | 23.8M | 6.4M | +36.84% |
| Q4 2020 | 2020-08-31 | 23.7M | 6.3M | +36.20% |
| Q3 2020 | 2020-05-31 | 23.3M | 5.9M | +33.90% |
| Q2 2020 | 2020-02-29 | 23.1M | 5.7M | +32.87% |
| Q1 2020 | 2019-11-30 | 17.4M | 22,253 | +0.13% |
| Q4 2019 | 2019-08-31 | 17.4M | 13,484 | +0.08% |
| Q3 2019 | 2019-05-31 | 17.4M | 2.9M | +20.14% |
| Q2 2019 | 2019-02-28 | 17.4M | 3.0M | +20.65% |
| Q1 2019 | 2018-11-30 | 17.4M | 3.1M | +21.46% |
| Q4 2018 | 2018-08-31 | 17.4M | 3.7M | +27.08% |
| Q3 2018 | 2018-05-31 | 14.5M | 1.1M | +8.63% |
| Q2 2018 | 2018-02-28 | 14.4M | 1.1M | +8.38% |
| Q1 2018 | 2017-11-30 | 14.3M | 1.0M | +7.84% |
| Q4 2017 | 2017-08-31 | 13.7M | 485,105 | +3.68% |
| Q3 2017 | 2017-05-31 | 13.3M | 188,258 | +1.43% |
| Q2 2017 | 2017-02-28 | 13.3M | 181,823 | +1.39% |
| Q1 2017 | 2016-11-30 | 13.3M | 1.7M | +14.36% |
| Q4 2016 | 2016-08-31 | 13.2M | 1.6M | +14.01% |
| Q3 2016 | 2016-05-31 | 13.1M | 2.3M | +21.17% |
| Q2 2016 | 2016-02-29 | 13.1M | 2.3M | +21.16% |
| Q1 2016 | 2015-11-30 | 11.6M | 790,181 | +7.31% |
| Q4 2015 | 2015-08-31 | 11.6M | 1.5M | +14.46% |
| Q3 2015 | 2015-05-31 | 10.8M | 880,569 | +8.84% |
| Q2 2015 | 2015-02-28 | 10.8M | 1.0M | +10.68% |
| Q1 2015 | 2014-11-30 | 10.8M | 2.9M | +36.04% |
| Q4 2014 | 2014-08-31 | 10.1M | 2.2M | +27.27% |
| Q3 2014 | 2014-05-31 | 10.0M | −76.8M | −88.52% |
| Q2 2014 | 2014-02-28 | 9.8M | −1.03B | −99.06% |
| Q1 2014 | 2013-11-30 | 7.9M | −78.5M | −90.80% |
| Q4 2013 | 2013-08-31 | 7.9M | −1.03B | −99.24% |
| Q3 2013 | 2013-05-31 | 86.7M | −12.37B | −99.30% |
| Q2 2013 | 2013-02-28 | 1.04B | −10.49B | −90.98% |
| As of Jan 23, 2013 | 2013-01-23 | 86.4M | −10.05B | −99.15% |
| As of Jan 22, 2013 | 2013-01-22 | 1.04B | −9.07B | −89.73% |
| Q1 2013 | 2012-11-30 | 12.46B | 2.36B | +23.39% |
| Q4 2012 | 2012-08-31 | 11.53B | 1.44B | +14.22% |
| Q3 2012 | 2012-05-31 | 10.14B | — | — |
| Q2 2012 | 2012-02-29 | 10.11B | — | — |
| Q1 2012 | 2011-11-30 | 10.10B | — | — |
| Q4 2011 | 2011-08-31 | 10.10B | — | — |
Oramed Pharmaceuticals shares outstanding trends
Over the last five reported fiscal years, Oramed Pharmaceuticals's shares outstanding moved from 23.7M to 39.3M, a change of 15.6M. The latest reported quarter, Q2 2026, shows 41.3M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oramed Pharmaceuticals filings at SEC.gov ↗